DELFT, THE NETHERLANDS — Vivici BV closed a seed funding round to supply animal-free dairy proteins formulated with precision fermentation to the market.

The funding round had support from DSM-Firmenich Venturing and Fonterra. Specific figures for the funding round were not available.

"Vivici is an exciting opportunity to combine DSM-Firmenich's world-leading precision fermentation expertise with Fonterra's world-leading dairy science and technology,” said Komal Mistry-Mehta, Fonterra chief innovation and brand officer. “This partnership aligns well with the co-op's strategy to be a leader in dairy innovation and science."

Pieter Wolters, managing director of DSM Venturing, added: "We are thrilled to be a founding investor in Vivici BV's Series Seed capital raise. Vivici has the foundation for success and builds on multiple years of joint technology and application development and is now well-positioned as an agile startup company."

Vivici is a business-to-business ingredients company that supplies food and beverage brands with animal-free dairy proteins, formulated with precision fermentation.

"I'm thrilled to work with such an experienced team, that knows what it takes to not only develop, but manufacture, register and commercialize great ingredients,” said Stephan van Sint Fiet, chief executive officer of Vivici.

“Together, we will build Vivici into a precision fermentation leader that contributes to a future-proof food system."